From:
`To:
`Cc:
`Subject:
`Date:
`
`Trials
`Snedden, Sheridan; Hulse, Tina; Paulraj, Christopher
`Trials
`FW: Mylan Pharmaceuticals et al. v. Saint Regis Mohawk Tribe, Case IPR2016-01127 (US 8,685,930 B2), et al.
`Thursday, October 26, 2017 12:53:33 PM
`
`Please see below
`
`Thanks
`Andrew
`
`From: Dzwonczyk, Michael R. [mailto:mdzwonczyk@sughrue.com]
`Sent: Thursday, October 26, 2017 3:38 PM
`To: Parmelee, Steve <sparmelee@wsgr.com>; Thorne, John <jthorne@kellogghansen.com>; Trials
`<Trials@USPTO.GOV>
`Cc: Rosato, Michael <mrosato@wsgr.com>; Mills, Jad <jmills@wsgr.com>;
`'gspeier@carlsoncaspers.com' <gspeier@carlsoncaspers.com>; 'mschuman@carlsoncaspers.com'
`<mschuman@carlsoncaspers.com>; Kokabi, Azy S. <akokabi@sughrue.com>; Ribar, Travis B.
`<tribar@sughrue.com>; 'whelan@fr.com' <whelan@fr.com>; 'PTABInbound@fr.com'
`<PTABInbound@fr.com>; 'coletti@fr.com' <coletti@fr.com>; 'oakes@fr.com' <oakes@fr.com>;
`'achan@shorechan.com' <achan@shorechan.com>; 'jdepumpo@shorechan.com'
`<jdepumpo@shorechan.com>; Klineberg, Geoffrey M. <gklineberg@kellogghansen.com>; Torczon,
`Richard <rtorczon@wsgr.com>
`Subject: RE: Mylan Pharmaceuticals et al. v. Saint Regis Mohawk Tribe, Case IPR2016-01127 (US
`8,685,930 B2), et al.
`
`Your Honors,
`
`Akorn does not object to HTIA's request below to submit an amicus brief in this matter.
`
`Respectfully,
`Mike Dzwonczyk
`Counsel for Akorn, Inc.
`
`
`From: Parmelee, Steve [mailto:sparmelee@wsgr.com]
`Sent: Thursday, October 26, 2017 9:49 AM
`To: Thorne, John; 'trials@uspto.gov'
`Cc: Rosato, Michael; Mills, Jad; 'gspeier@carlsoncaspers.com'; 'mschuman@carlsoncaspers.com';
`Dzwonczyk, Michael R.; Kokabi, Azy S.; Ribar, Travis B.; 'whelan@fr.com';
`'PTABInbound@fr.com'; 'coletti@fr.com'; 'oakes@fr.com'; 'achan@shorechan.com';
`'jdepumpo@shorechan.com'; Klineberg, Geoffrey M.; Torczon, Richard
`Subject: RE: Mylan Pharmaceuticals et al. v. Saint Regis Mohawk Tribe, Case IPR2016-01127
`(US 8,685,930 B2), et al.
`
`Your Honors,
`
`Petitioners have no objection to the High Tech Inventors Alliance filing a brief as amicus
`curiae in this matter, as requested in Mr. Thorne’s email below submitted to the Board
`yesterday.
`
`

`

`
`Respectfully,
`
`Steven W. Parmelee
`Lead Counsel for Petitioner
`Wilson Sonsini Goodrich & Rosati
`701 Fifth Avenue, Suite 5100
`Seattle, WA 98104
`206-883-2542 Direct
`sparmelee@wsgr.com | www.wsgr.com
`
`
`From: Thorne, John [mailto:jthorne@kellogghansen.com]
`Sent: Wednesday, October 25, 2017 2:01 PM
`To: 'trials@uspto.gov'
`Cc: Parmelee, Steve; Rosato, Michael; Mills, Jad; 'gspeier@carlsoncaspers.com';
`'mschuman@carlsoncaspers.com'; 'mdzwonczyk@sughrue.com'; 'akokabi@sughrue.com';
`'tribar@sughrue.com'; 'whelan@fr.com'; 'PTABInbound@fr.com'; 'coletti@fr.com';
`'oakes@fr.com'; 'achan@shorechan.com'; 'jdepumpo@shorechan.com'; Klineberg, Geoffrey M.
`Subject: Mylan Pharmaceuticals et al. v. Saint Regis Mohawk Tribe, Case IPR2016-01127 (US
`8,685,930 B2), et al.
`
`To: The Patent Trial and Appeal Board
`cc: Counsel for all parties
`
`The High Tech Inventors Alliance respectfully requests leave to file a brief as amicus curiae
`on the question presented in the motion to dismiss filed by Patent Owner Saint Regis
`Mohawk Tribe (Paper No. 93). The HTIA is a nonprofit corporation whose members are as
`follows: Adobe Systems, Inc.; Amazon.com, Inc.; Cisco Systems, Inc.; Dell Inc.; Google Inc.;
`Intel Corporation; Oracle Corporation; and salesforce.com, inc.
`
`HTIA is dedicated to advancing a patent system that promotes investment in new
`technologies and American jobs. HTIA’s members employ nearly 500,000 U.S. employees,
`including many of the world’s most innovative computer scientists and engineers.
`Collectively, they spent $63 billion in 2016 on research and development, hold over 115,000
`U.S. patents, and have a market capitalization over $1.75 trillion. As frequent users of the
`Patent and Trademark Office’s inter partes review process, HTIA’s members are also keenly
`interested in ensuring that the IPR process remains available to resolve questions of
`patentability in an efficient and timely manner.
`
`The issue raised by the Tribe in its motion to dismiss—namely, whether tribal sovereign
`immunity applies in IPR proceedings—is exceptionally important because its resolution may
`prove critical to the continuing availability of the IPR process. HTIA believes that it could
`provide the Patent Trial and Appeal Board with a useful perspective on the legal question
`presented here that will help inform the Board’s disposition of the motion to dismiss.
`
`HTIA requests that it be permitted to file its brief within three weeks of the Board’s decision
`
`

`

`on this request. HTIA also asks leave to include potentially other parties on its amicus brief,
`but HTIA and any others joining its brief will file only a single brief. Earlier this afternoon,
`HTIA sent emails to counsel for all parties in this proceeding, seeking their consent to this
`request. Although counsel for the Patent Owner indicated that they do not consent, we
`have not heard back from other counsel. All counsel are copied on this email.
`
`Thank you for your consideration.
`
`Respectfully submitted,
`
`John Thorne
`
`
`John Thorne
`KELLOGG, HANSEN, TODD, FIGEL & FREDERICK, P.L.L.C.
`Sumner Square | 1615 M Street, N.W. | Suite 400 | Washington, DC 20036
`office 202-326-7992 / mobile 202-365-7992 | fax 202-326-7999
`
`NOTICE: This transmission is intended only for the use of the addressee and may contain information that is
`privileged, confidential and exempt from disclosure under applicable law. If you are not the intended recipient, or
`the employee or agent responsible for delivering the message to the intended recipient, you are hereby notified
`that any dissemination, distribution or copying of this communication is strictly prohibited. If you have received this
`communication in error, please notify the sender immediately via reply e-mail, and then destroy all instances of this
`communication. Thank you.
`
`
`This email and any attachments thereto may contain private, confidential, and
`privileged material for the sole use of the intended recipient. Any review, copying, or
`distribution of this email (or any attachments thereto) by others is strictly prohibited.
`If you are not the intended recipient, please contact the sender immediately and
`permanently delete the original and any copies of this email and any attachments
`thereto.
`
`Michael R. Dzwonczyk
`
`Sughrue Mion, PLLC | 2100 Pennsylvania Ave., N. W. Washington, DC 20037| Office: 202-857-3233 | Fax: 202-293-7860
`mdzwonczyk@sughrue.com - www.sughrue.com
`
`Warning: In rare cases, our e-mail filtering software may eliminate legitimate email
`from clients unnoticed. Therefore, if your mail contains important instructions, please
`make sure that we acknowledge receipt of those instructions.
`
`This message is intended only for the designated recipient(s). It may contain confidential or
`proprietary information and may be subject to the attorney-client privilege or other
`
`

`

`confidentiality protections. If you are not a designated recipient, you may not review, copy or
`distribute this message. If you receive this in error, please notify the sender by reply e-mail to
`coordinate retrieval or deletion of this message. Thank you.
`
`